DE60315597D1 - Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen - Google Patents

Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen

Info

Publication number
DE60315597D1
DE60315597D1 DE60315597T DE60315597T DE60315597D1 DE 60315597 D1 DE60315597 D1 DE 60315597D1 DE 60315597 T DE60315597 T DE 60315597T DE 60315597 T DE60315597 T DE 60315597T DE 60315597 D1 DE60315597 D1 DE 60315597D1
Authority
DE
Germany
Prior art keywords
treatment
acid derivatives
haloacetamidobenzoic
illnesses
parasitic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60315597T
Other languages
English (en)
Other versions
DE60315597T2 (de
Inventor
Patrice Lepape
Esther Suzy Fellous
Julius George Bekesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60315597D1 publication Critical patent/DE60315597D1/de
Application granted granted Critical
Publication of DE60315597T2 publication Critical patent/DE60315597T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60315597T 2002-01-31 2003-01-31 Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen Expired - Lifetime DE60315597T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0201151A FR2835253B1 (fr) 2002-01-31 2002-01-31 Composes, en particulier de derives urees ou esters de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires
FR0201151 2002-01-31
PCT/FR2003/000289 WO2003063858A2 (fr) 2002-01-31 2003-01-31 Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires

Publications (2)

Publication Number Publication Date
DE60315597D1 true DE60315597D1 (de) 2007-09-27
DE60315597T2 DE60315597T2 (de) 2008-05-08

Family

ID=27619780

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60315597T Expired - Lifetime DE60315597T2 (de) 2002-01-31 2003-01-31 Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen

Country Status (10)

Country Link
US (1) US20050165068A1 (de)
EP (1) EP1469845B1 (de)
CN (1) CN100490799C (de)
AT (1) ATE369849T1 (de)
AU (1) AU2003216965A1 (de)
BR (1) BR0307039A (de)
DE (1) DE60315597T2 (de)
ES (1) ES2295567T3 (de)
FR (1) FR2835253B1 (de)
WO (1) WO2003063858A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016179505A1 (en) * 2015-05-06 2016-11-10 University Of Maryland, College Park Compounds for treating parasitic infections
US10399966B2 (en) 2016-01-21 2019-09-03 University Of Washington Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
CN110996939A (zh) * 2017-08-03 2020-04-10 诺克斯生物公司 用于治疗皮肤利什曼病的方法的组合物
EP3449906A1 (de) 2017-09-04 2019-03-06 AC Biotech Topische zusammensetzungen zur verwendung in der behandlung von kutaner leishmaniose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE106502C (de) *
JPS5848545B2 (ja) * 1974-04-18 1983-10-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
US5886025A (en) * 1997-03-06 1999-03-23 Baylor University Anti-mitotic agents which inhibit tubulin polymerization
WO1999048491A1 (fr) * 1998-03-20 1999-09-30 Suntory Limited INHIBITEURS DE NF-λB CONTENANT DU PHENYLMETHYL-BENZOQUINONE EN TANT QU'INGREDIENT ACTIF
US6294695B1 (en) * 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
WO2001016357A2 (en) * 1999-08-30 2001-03-08 K.U. Leuven Research & Development Novel target for antiparasitic agents and inhibitors thereof
US7259278B2 (en) * 2000-11-29 2007-08-21 Cytoskeleton Inc. Anti-S-phase tubulin ligands

Also Published As

Publication number Publication date
EP1469845A2 (de) 2004-10-27
FR2835253A1 (fr) 2003-08-01
BR0307039A (pt) 2004-10-26
FR2835253B1 (fr) 2008-02-01
EP1469845B1 (de) 2007-08-15
CN1625396A (zh) 2005-06-08
ATE369849T1 (de) 2007-09-15
US20050165068A1 (en) 2005-07-28
ES2295567T3 (es) 2008-04-16
DE60315597T2 (de) 2008-05-08
AU2003216965A1 (en) 2003-09-02
WO2003063858A2 (fr) 2003-08-07
CN100490799C (zh) 2009-05-27
WO2003063858A3 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
BG108450A (en) Aromatic dicarboxylic acid derivatives
BR0312729A (pt) Novos derivados de indol-3-enxofre
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE408601T1 (de) Fredericamycin-derivate
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
BR0012450A (pt) Benzimidazóis substituìdos
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
SE9903894D0 (sv) Novel compounds
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
NO20054418L (no) Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
ATE391710T1 (de) Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament
DE60315597D1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen
MA27649A1 (fr) Derives d&#39;acylphenyluree substitues par carbonylamino, methode de production et d&#39;utilisation de ceux-ci.
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados

Legal Events

Date Code Title Description
8364 No opposition during term of opposition